Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans

Diabetes Care

Volumn 33, Issue 2, 2010, Pages 405-407

  Stefan, Norbert ^a   Kantartzis, Konstantinos ^a   Celebi, Nora ^a   Staiger, Harald ^a   Machann, Jürgen ^a   Schick, Fritz ^a   Cegan, Alexander ^b   Elcnerova, Michaela ^b   Schleicher, Erwin ^a   Fritsche, Andreas ^a   Häring, Hans Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF PARDUBICE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID; FATTY ACID DERIVATIVE; PALMITOLEATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; LIFE STYLE; MALE; MICE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; SPORTS; VISCERA;

EID: 75149114696     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0544     Document Type: Article

References (15)

1. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009;48:44-51
2. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-520
3. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-3025
4. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606
5. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-1616
6. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 2004;19:92-96
7. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008;134:933-944
8. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857
9. Stefan N, Wahl HG, Fritsche A, Haring H, Stumvoll M. Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res 2001;33:432-438
10. Petersson H, Basu S, Cederholm T, Risérus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic in-flammation: longitudinal analyses in middle-aged men. Br J Nutr 2008;99:1186-1189
11. Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of fatty liver. Endocr Rev 2008;29:939-960
12. Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006;2:335-348
13. Furuhashi M, Hotamisligil GS. Fatty acidbinding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008;7:489-503
14. Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil GS, Thörne A, Rydén M, Hamsten A, Arner P. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001;44:1268-1273
15. Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, Chatterjee VK, Frayn KN, O'Rahilly S, Karpe F. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptorgamma. Diabetes 2005;54:1379-1384